Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: Biofeedback Training in Patients With Advanced Lung Cancer - A Pilot Study [NA]
This document reports the termination of a pilot clinical trial evaluating biofeedback training in patients with advanced non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-) [Phase 2]
Clinical trial update evaluating erlotinib as second- or third-line therapy in non-small cell lung cancer patients with EGFR mutation-negati…
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated imatinib (Gleevec) in combination with weekly paclitaxel in patients aged 70 and older with advanced non-small cel…
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy [Phase 3]
A Phase 3 clinical trial evaluating icotinib in advanced/metastatic non-small cell lung cancer patients previously treated with chemotherapy…
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer [Phase 1]
Phase 1 trial of ridaforolimus with cetuximab in non-small cell lung cancer is terminated; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients [Phase 1]
Phase 1 safety study of Imexon plus Docetaxel in non-small cell lung cancer, breast cancer, and prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02) [NA]
Clinical trial update for proton therapy with chemotherapy in stage III non-small cell lung cancer; study terminated with results posted in …
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy [Phase 2]
Phase 2 study evaluating the safety and activity of pertuzumab in advanced non-small cell lung cancer after prior chemotherapy; the study ha…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial evaluating the efficacy of additional chemotherapy after concurrent chemoradiation in non-small cell lung cancer has …
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: A Study of LY2875358 in Japanese Participants With Advanced Cancer [Phase 1]
Phase 1 clinical trial of LY2875358 in Japanese participants with advanced cancer has completed, including non-small cell lung cancer and ly…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC [Phase 1]
Phase I trial evaluating docetaxel with low-dose fractionated radiation for metastatic or recurrent non-small cell lung cancer; the study ha…
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib [Phase 2]
A Phase 2 trial evaluating sorafenib with erlotinib or sorafenib alone in advanced non-small cell lung cancer progressing on erlotinib, with…
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations [Phase 4]
Phase 4 study evaluating Tarceva (erlotinib) in patients with EGFR-mutant locally advanced or metastatic non-small cell lung cancer. Results…
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC) [Phase 2]
A phase II trial evaluating docetaxel/gemcitabine followed by chemoradiotherapy (with or without consolidation chemotherapy) for stage IIIA/…
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Non-small Cell Lung Cancer and Quality of Life
A completed clinical trial focusing on non-small cell lung cancer and quality of life, sponsored by the University of Turku.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer [Phase 2]
This is a Phase II study of radiation therapy combined with paclitaxel poliglumex and carboplatin for stage III non-small cell lung cancer; …
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating a tiotropium inhaler to treat shortness of breath in patients with advanced non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Health Related Quality of Life After Video Assisted Thoracoscopic Lobectomy for Lung Cancer
Clinical trial update reporting health-related quality of life after video-assisted thoracoscopic lobectomy for operable early-stage non-sma…
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation [Phase 2]
This update describes a Phase 2 trial evaluating icotinib as adjuvant therapy for patients with EGFR-mutant non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy [Phase 4]
A Phase 4 trial evaluating an increased dose of icotinib in patients with non-small cell lung cancer who previously received gefitinib is cu…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC. [Phase 2]
Phase 2 study of the CDK4/6 inhibitor PD0332991 (palbociclib) in advanced non-small cell lung cancer has been completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 clinical trial update for ganetespib in ALK-positive non-small cell lung cancer, with the study status listed as completed.
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Trial of Poor Performance Status Patients (ToPPS) [Phase 2]
Phase 2 trial update (ToPPS) in patients with non-small cell lung cancer and poor performance status. The study is completed and results wer…
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC [Phase 1, Phase 2]
A completed Phase 1/Phase 2 trial investigated carboplatin plus gemcitabine in elderly patients with stage IV non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC [Phase 2]
Phase 2 trial evaluating adding bevacizumab and erlotinib to carboplatin and docetaxel versus chemotherapy alone in resected non-small cell …